Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Bachstetter, Adam D.
Späni, Claudia B.
Roy, Saktimayee M.
Watterson, D. Martin
Van Eldik, Linda J.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01 NS093920)
National Institute on Aging (U01 AG043415)